CI
ONC

Conning Inc’s BeOne Medicines Ltd ONC Stock Holding History

Conning Inc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-53,451
Closed -$5.53M – 628
2017
Q3 		$5.53M Hold
53,451
– – 0.19% 96
2017
Q2 		$2.4M Sell
53,451
-107,799
-67% -$4.25M 0.09% 163
2017
Q1 		$5.9M Hold
161,250
– – 0.22% 87
2016
Q4 		$4.9M Buy
+161,250
New +$5.07M 0.2% 97

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Conning Inc's ONC Position: Q4 2017 in Review

Conning Inc sold out of BeOne Medicines Ltd (ONC) in Q4 2017, closing a stake of 53,451 shares — an estimated $5.53M sold.

Conning Inc first reported a position in ONC in Q4 2016 and held it in 4 quarters. The position peaked at $5.9M in Q1 2017. 93 funds tracked by Wall St. Rank hold ONC as of Q4 2017.

  • Conning Inc reported no remaining BeOne Medicines Ltd position as of Q4 2017 after selling out during the quarter.
  • Conning Inc sold 53,451 BeOne Medicines Ltd shares in Q4 2017, an estimated $5.53M.
  • Conning Inc first reported a position in BeOne Medicines Ltd in Q4 2016 and held it in 4 quarters.
  • Conning Inc's BeOne Medicines Ltd position peaked at $5.9M in Q1 2017.
  • 93 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2017.

Based on Conning Inc's 13F filing for Q4 2017, filed 30 Jan 2018.